Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.
Condition: Invasive Group B Streptococcus DiseaseIntervention: Sponsors: Novartis Vaccines; NovartisRecruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials